down arrow

China Pharma Holdings, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US16941T2033
USD
1.66
-0.14 (-7.78%)

Dec 04

ASE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
China Pharma Holdings, Inc.
InMed Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc.
Avalo Therapeutics, Inc.
Allarity Therapeutics, Inc.
Galmed Pharmaceuticals Ltd.
Adial Pharmaceuticals, Inc.
Dermata Therapeutics, Inc.
NeuBase Therapeutics, Inc.
Baudax Bio, Inc.
China Sxt Pharmaceuticals, Inc.
Why is China Pharma Holdings, Inc. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Icon
No Data Found
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-16.68%
EBIT Growth (5y)
-6.99%
EBIT to Interest (avg)
-3.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.43
Sales to Capital Employed (avg)
0.54
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.37%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.74
EV to EBIT
-1.89
EV to EBITDA
-3.77
EV to Capital Employed
0.82
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-43.26%
ROE (Latest)
-63.86%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 0.42 MM

ROCE(HY)

Highest at -52.05%

RAW MATERIAL COST(Y)

Fallen by -79.68% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.6 times

OPERATING PROFIT(Q)

Highest at USD -0.33 MM

PRE-TAX PROFIT(Q)

Highest at USD -0.53 MM

NET PROFIT(Q)

Highest at USD -0.53 MM

EPS(Q)

Highest at USD -0.16

-4What is not working for the Company
NET SALES(9M)

At USD 3.3 MM has Grown at -25.84%

CASH AND EQV(HY)

Lowest at USD 1.04 MM

Here's what is working for China Pharma Holdings, Inc.
Operating Cash Flow
Highest at USD 0.42 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD -0.33 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -0.53 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -0.53 MM has Grown at 63.26%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -0.53 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -0.53 MM has Grown at 63.26%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.16
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Inventory Turnover Ratio
Highest at 2.6 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -79.68% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for China Pharma Holdings, Inc.
Net Sales
At USD 3.3 MM has Grown at -25.84%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Cash and Eqv
Lowest at USD 1.04 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."